Taxus Cardium Pharmaceuticals Group (CRXM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2009 | 06-2009 | 03-2009 | 12-2008 | 09-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -20,997 | -25,880 | -14,737 | -24,598 | -19,520 |
| Depreciation Amortization | 5,795 | 4,569 | 1,690 | 2,092 | 1,310 |
| Accounts receivable | -80 | 126 | 17 | 275 | 443 |
| Accounts payable and accrued liabilities | -485 | 526 | -214 | 3,284 | 3,197 |
| Other Working Capital | -385 | 2,270 | 248 | 3,204 | 3,518 |
| Other Operating Activity | 7,349 | 14,193 | 10,141 | -871 | -1,007 |
| Operating Cash Flow | $-8,801 | $-4,196 | $-2,854 | $-16,614 | $-12,060 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | -682 | -624 |
| Purchase Sale Intangibles | N/A | N/A | N/A | -1,000 | -1,000 |
| Other Investing Activity | 0 | 0 | 0 | -1,000 | -1,000 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $-1,682 | $-1,624 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 3,912 | 3,966 | N/A | 5,489 | N/A |
| Debt Repayment | -6,779 | -100 | N/A | -4,864 | -4,864 |
| Common Stock Issued | 4,858 | 0 | 3,178 | 10,950 | 10,950 |
| Other Financing Activity | 10,125 | 0 | 0 | 100 | 0 |
| Financing Cash Flow | $12,117 | $3,866 | $3,178 | $11,676 | $6,087 |
| Beginning Cash Position | 1,103 | 1,103 | 1,103 | 7,723 | 7,723 |
| End Cash Position | 4,419 | 773 | 1,427 | 1,103 | 127 |
| Net Cash Flow | $3,316 | $-330 | $324 | $-6,620 | $-7,596 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,801 | -4,196 | -2,854 | -16,614 | -12,060 |
| Capital Expenditure | N/A | N/A | N/A | -682 | -624 |
| Free Cash Flow | -8,801 | -4,196 | -2,854 | -17,295 | -12,683 |